The central role of TGF-β in promoting fibrovascular pathology and subsequent organ dysfunction has been reinforced by multiple studies demonstrating the beneficial effects of blocking TGF-β for either chronic renal [28], [29] or cardiac disease [30], [31]. This evidence concerns the gene TGFB1 and heart disorder.